Quantification of cAMP antagonist action in vitro and in living cells

Aandahl, 1998, Protein kinase A type I antagonist restores immune responses of T cells from HIV-infected patients, FASEB J., 12, 855, 10.1096/fasebj.12.10.855 Aandahl, 1999, Additive effects of IL-2 and protein kinase A type I antagonist on function of T cells from HIV-infected patients on HAART, Aids, 13, F109, 10.1097/00002030-199912030-00001 Arunlakshana, 1959, Some quantitative uses of drug antagonists, Br. J. Pharmacol., 14, 48 Bradford, 1976, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem., 72, 248, 10.1016/0003-2697(76)90527-3 Burns-Hamuro, 2003, Designing isoform-specific peptide disruptors of protein kinase A localization, Proc. Natl. Acad. Sci. USA, 100, 4072, 10.1073/pnas.2628038100 Cho-Chung, 1995, cAMP-dependent protein kinase: role in normal and malignant growth, Crit. Rev. Oncol. Hematol., 21, 33, 10.1016/1040-8428(94)00166-9 Cook, 1982, Adenosine cyclic 3′,5′-monophosphate dependent protein kinase: kinetic mechanism for the bovine skeletal muscle catalytic subunit, Biochemistry, 21, 5794, 10.1021/bi00266a011 Gjertsen, 1995, Novel (Rp)-cAMPS analogs as tools for inhibition of cAMP-kinase in cell culture, J. Biol. Chem., 270, 20599, 10.1074/jbc.270.35.20599 Herberg, 1999, Analysis of protein kinase interactions using biomolecular interaction analysis, vol. 2, 335 Herberg, 1994, Crosstalk between domains in the regulatory subunit of cAMP-dependent protein kinase: influence of amino terminus on cAMP binding and holoenzyme formation, Biochemistry, 33, 7485, 10.1021/bi00189a057 Kammer, 1999, High prevalence of T cell type I protein kinase A deficiency in systemic lupus erythematosus, Arthritis Rheum., 42, 1458, 10.1002/1529-0131(199907)42:7<1458::AID-ANR20>3.0.CO;2-P Kim, 2005, Crystal structure of a complex between the catalytic and regulatory (RI{alpha}) subunits of PKA, Science, 307, 690, 10.1126/science.1104607 Kopperud, 2002, Formation of inactive cAMP-saturated holoenzyme of cAMP-dependent protein kinase under physiological conditions, J. Biol. Chem., 277, 13443, 10.1074/jbc.M109869200 Kruppa, 1997, Bioactivatable derivatives of 8-substituted cAMP-analogues, Bioorg. Med. Chem. Lett., 7, 945, 10.1016/S0960-894X(97)00136-4 Laemmli, 1970, Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature, 227, 680, 10.1038/227680a0 Langeberg, 2005, A-kinase-anchoring proteins, J. Cell Sci., 118, 3217, 10.1242/jcs.02416 Lehnart, 2005, Phosphodiesterase 4D deficiency in the ryanodine-receptor complex promotes heart failure and arrhythmias, Cell, 123, 25, 10.1016/j.cell.2005.07.030 Motulsky, 2003, Dose–response curves in the presence of antagonists, 276 Nesterova, 1995, A single-injection protein kinase A-directed antisense treatment to inhibit tumour growth, Nat. Med., 1, 528, 10.1038/nm0695-528 Olsen, 1989, Affinity purification of the C alpha and C beta isoforms of the catalytic subunit of cAMP-dependent protein kinase, J. Biol. Chem., 264, 18662, 10.1016/S0021-9258(18)51518-0 Prinz, 2004, Monitoring cAMP dependent protein kinase subunit interaction in intact cells using bioluminescence resonance energy transfer (BRET), FASEB J., 18, C159 Rothermel, 1988, A mechanistic and kinetic analysis of the interactions of the diastereoisomers of adenosine 3′,5′-(cyclic)phosphorothioate with purified cyclic AMP-dependent protein kinase, Biochem. J., 251, 757, 10.1042/bj2510757 Sambrook, 2001, Purification of fusion proteins by affinity chromatography on glutathione agarose, 15.36 Schaap, 1993, Cell-permeable non-hydrolyzable cAMP derivatives as tools for analysis of signaling pathways controlling gene regulation in Dictyostelium, J. Biol. Chem., 268, 6323, 10.1016/S0021-9258(18)53256-7 Schultz, 1993, Acetoxymethyl esters of phosphates, enhancement of the permeability and potency of cAMP, J. Biol. Chem., 268, 6316, 10.1016/S0021-9258(18)53255-5 Schwechheimer, 1977, Properties of regulatory subunit of cyclic AMP-dependent protein kinase (peak I) from rabbit skeletal muscle prepared by urea treatment of the holoenzyme, J. Biol. Chem., 252, 7690, 10.1016/S0021-9258(17)41023-4 Wu, 2004, Biochemistry, 43, 6620, 10.1021/bi0302503 Yonemoto, 1991, Prokaryotic expression of catalytic subunit of adenosine cyclic monophosphate-dependent protein kinase, Methods Enzymol., 200, 581, 10.1016/0076-6879(91)00173-T